Quantitative haemagglutination. 4. Effect of neuraminidase treatment on agglutination by blood group antibodies.
D000017:ABO Blood-Group System; D001789:Blood Group Antigens; D004347:Drug Interactions; D004906:Erythrocyte Count; D004912:Erythrocytes / Q000187:drug effects; D006384:Hemagglutination / Q000187:drug effects*; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D066298:In Vitro Techniques; D007518:Isoantibodies; D009438:Neuraminic Acids; D009439:Neuraminidase / Q000494:pharmacology*; D012204:Rh-Hr Blood-Group System
D000017:ABO Blood-Group System; D001789:Blood Group Antigens; D007518:Isoantibodies; D009438:Neuraminic Acids; D012204:Rh-Hr Blood-Group System; D009439:Neuraminidase